Renal Failure Chronic Requiring Hemodialysis

Nephrology
2
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Rockwell Medical
2 programs
2
Soluble Ferric PyrophosphatePhase 31 trial
Soluble Ferric PyrophosphatePhase 31 trial
Active Trials
NCT01322347CompletedEst. Feb 2014
NCT01320202CompletedEst. Nov 2013
Merit Medical
Merit MedicalSOUTH JORDAN, UT
1 program
HeRO Vascular Access DeviceN/A1 trial
Active Trials
NCT00890045Completed72Est. Mar 2008

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Rockwell MedicalSoluble Ferric Pyrophosphate
Rockwell MedicalSoluble Ferric Pyrophosphate
Merit MedicalHeRO Vascular Access Device

Clinical Trials (3)

Total enrollment: 72 patients across 3 trials

NCT01322347Rockwell MedicalSoluble Ferric Pyrophosphate

Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2)

Start: Apr 2011Est. completion: Feb 2014
Phase 3Completed
NCT01320202Rockwell MedicalSoluble Ferric Pyrophosphate

Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients

Start: Mar 2011Est. completion: Nov 2013
Phase 3Completed
NCT00890045Merit MedicalHeRO Vascular Access Device

Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study

Start: Jul 2004Est. completion: Mar 200872 patients
N/ACompleted

Related Jobs in Nephrology

Thesis work, 60 credits – Establishing In Vitro Models of Mitochondrial Dysfunction in Acute Kidney Injury for Preclinical Drug Discovery

AstraZeneca
Sweden - Gothenburg
1w ago

Associate Director – Nephrology Market Access Strategy

Biogen
Cambridge, MA
1w ago
$164K - $226K/yr

Director, Strategy & Operations-Nephrology Franchise

Biogen
Cambridge, MA
1w ago
$195K - $269K/yr

Medical Science Liaison, CardioRenal - Portland, OR

AstraZeneca
Portland - OR, US
1w ago

Vice President, Head of Renal Sales

Novartis
Field Non-Sales (USA)
1w ago
$274K - $510K/yr

Specialty Account Manager, Nephrology- South Houston, Texas

Amgen
Texas - Houston, US
1w ago
$155K - $184K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space

Related Indications

Chronic Kidney Disease(86)Renal Impairment(67)End Stage Renal Disease(56)Kidney Transplantation(49)Renal Insufficiency(27)Chronic Kidney Diseases(25)Kidney Transplant(19)Diabetic Nephropathies(18)Kidney Diseases(17)Kidney Transplant Rejection(16)